This week another Canadian article on the renaissance of psychedelics hit the press. From The Star in Toronto, it examines some of the recent evolution in laws governing the use of psychedelics and stories on their use by some of the Canadians recently approved to use magic mushrooms to treat their depression.

“Researchers say the government’s recent decision to allow terminally ill Canadians to use psilocybin is an example of the psychedelic sphere opening up, leading some to say the class of drugs, also known as hallucinogens, is having its moment in the mainstream.”

“And amid the growing buzz around psychedelics, there’s been an exponential explosion in research into LSD, psilocybin, MDMA and ketamine to treat conditions such as depression, post-traumatic stress disorder (PTSD), anxiety and substance-use disorder. This comes at a time when Canadians are experiencing more mental health challenges due to the COVID-19 pandemic.”

Here’s a link to the full article:

https://www.thestar.com/news/canada/2020/10/25/mental-illness-is-on-the-rise-due-to-covid-19-could-psychedelic-drugs-be-the-game-changer.html